ABROCITINIB

3948 reported adverse events

Drug classes: Janus Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ABROCITINIB:

# Side effect Count
0 DRUG INEFFECTIVE 537
1 CONDITION AGGRAVATED 366
2 OFF LABEL USE 323
3 PRURITUS 247
4 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 208
5 RASH 184
6 DERMATITIS ATOPIC 179
7 NAUSEA 166
8 HEADACHE 109
9 ECZEMA 95
See all common reactions for ABROCITINIB

ABROCITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAMILIAL HYPERTRIGLYCERIDAEMIA 1 0.2000
1 ECZEMA HERPETICUM 42 0.0907
2 CARBOHYDRATE ANTIGEN 72-4 INCREASED 1 0.0833
3 ERYTHRODERMIC ATOPIC DERMATITIS 2 0.0800
4 HERPES SIMPLEX PHARYNGITIS 1 0.0417
5 CHEMOKINE INCREASED 1 0.0370
6 PENILE DERMATITIS 2 0.0317
7 ATYPICAL FIBROXANTHOMA 2 0.0267
8 HAEMORRHAGIC URTICARIA 1 0.0250
9 CANCER CELLS PRESENT 1 0.0233
See all enriched reactions for ABROCITINIB